Skip to main content
Caplight Logo









TenAces Biosciences

TenAces Biosciences

Private
IsraelHealthcare & Life Scienceshttp://tenaces.bio

Last Round

Seed

Jan 30, 2024

Company Overview

TenAces Biosciences is a biotechnology company that leverages machine learning and data-centric approaches to discover and develop molecular glue therapeutics for targeted protein degradation.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

molecular gluetargeted protein degradationTPDAI drug discoveryundruggable targetscomputational biologyrational drug designvirtual screeningprotein-ligand interactionbiotech startupin silico drug discoveryAI-first biotechsmall molecule therapeuticsdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TenAces Biosciences Comparables

Compare TenAces Biosciences with similar companies based on industry and business-model similarity.

TenAces Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ternary Therapeutics
95%
GluBio Therapeutics
86%
Degron Therapeutics
84%

TenAces Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 30, 2024

TenAces Biosciences Investors

Notable investors and investment history

TenAces Biosciences investors
InvestorRounds
Israel Biotech FundSeed
Amiti VenturesSeed
PfizerSeed
AION LabsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2024

    Seed round included investors Pfizer, Amiti Ventures, and Israel Biotech Fund.

TenAces Biosciences Filings

Explore SEC and related filing metadata, where available.

TenAces Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TenAces Biosciences's valuation, stock price, and market status.

Is TenAces Biosciences a public or private company?

TenAces Biosciences is a private company.

What is the current stock price of TenAces Biosciences?

TenAces Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is TenAces Biosciences worth (valuation)?

Valuation information for TenAces Biosciences is not publicly available.

Can I buy TenAces Biosciences stock?

TenAces Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TenAces Biosciences's last funding round?

TenAces Biosciences's most recent funding round was Seed on January 30, 2024.

Who are the main investors in TenAces Biosciences?

Key investors in TenAces Biosciences include Israel Biotech Fund, Amiti Ventures, Pfizer, AION Labs.

Will TenAces Biosciences IPO soon?

No public IPO plans have been announced for TenAces Biosciences.

How can I track TenAces Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TenAces Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Year Founded2024
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?